Creative Medical Technology Holdings Announces Implementation of Reverse Stock Split in Preparation for Planned Uplisting to The Nasdaq Capital Market

About this update from Creative Medical Technology Holdings, Inc.

[{"type":"text","content":"PHOENIX, Nov. 9, 2021 /PRNewswire/ -- (OTC-CELZ) Creative Medical Technology Holdings, Inc. (the \"Company\"), a commercial stage biotechnology company focused on immunology, urology, neurology and orthopedics using adult stem cell treatments and interrelated regenerative technologies for the treatment of multiple indications, today announced its intention to effect a 1-for-500 reverse split of its common stock in preparation for a planned listing of the Company's securities on The Nasdaq Capital Market (\"Nasdaq\"). The reverse stock split will become effective at the open of business on Wednesday, November 10, 2021, and the Company's common stock will begin trading on the OTC Markets system on a split-adjusted basis under the temporary ticker symbol \"CELZD\" at that time. The fifth character \"D\" will remain appended to the Company's symbol for 20 business days or until the Company is listed on Nasdaq, whichever comes first, at which point the Company's trading symbol will revert back to \"CELZ.\" The new CUSIP number for the Company's common stock is 22529Y 309.\n\n \n \n \n \n \n \n\n \nThe Company has filed an application to list its common stock and warrants on Nasdaq. The reverse stock split is intended to enable the Company to meet the stock price requirement for initial listing on The Nasdaq Capital Market. \n\"Our plan to list on the Nasdaq Capital Market is an important step forward for the Company. We believe that a listing on Nasdaq will raise our profile to the broader investment community, and ultimately create shareholder value,\" stated Timothy Warbington, Chief Executive Officer.\nUpon effectiveness of the reverse stock split, every 500 shares of the Company's common stock outstanding will be converted into one share of common stock, with any fractional shares rounded up to one whole share. Accordingly, the number of shares of common stock outstanding following the reverse stock split will be reduced from 1,226,141,742 shares to 2,452,348 shares. The reverse split will uniformly impact all stockholders, as it will not alter any stockholder's percentage equity interest in the Company, and not result in any dilution, except to the extent that the reverse split results in a stockholder owning a fractional share.\nAbout Creative Medical Technology Holdings\nCreative Medical Technology Holdings, Inc. is a commerci...

More updates from Creative Medical Technology Holdings, Inc.